Meeting Coverage:

American Society of Cataract and Refractive Surgery Meeting

ASCRS: 2024

Cyclosporine 0.09% Treatment Before Cataract Surgery

Show Description +

John Hovanesian, MD, shares highlights from his presentation during the ASCRS annual meeting on managing ocular surface disease before cataract surgery. He specifically discusses the use of cyclosporine 0.09%, detailing the outcomes of a study in which 50 patients with dry eye were treated with the solution for 28 days.

Posted: 4/10/2024

Cyclosporine 0.09% Treatment Before Cataract Surgery

John Hovanesian, MD, shares highlights from his presentation during the ASCRS annual meeting on managing ocular surface disease before cataract surgery. He specifically discusses the use of cyclosporine 0.09%, detailing the outcomes of a study in which 50 patients with dry eye were treated with the solution for 28 days.

Posted: 4/10/2024


Please log in to leave a comment.

More From ASCRS: 2024 Coverage